Lysophosphatidylcholine binds α-synuclein and prevents its pathological aggregation
National Science Review · 03.05.2024 · 11 (6)
DOI: 10.1093/nsr/nwae182 ↗Kurz gefasst
Fachartikel in der Zeitschrift National Science Review, online erschienen am 25.05.2024. Verfasst von Chunyu Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, Ch…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Major State Basic Research Development Program of China, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Accumulation of aggregated α-synuclein (α-syn) in Lewy bodies is the pathological hallmark of Parkinson's disease (PD). Genetic mutations in lipid metabolism are causative for a subset of patients with Parkinsonism. The role of α-syn's lipid interactions in its function and aggregation is recognized, yet the specific lipids involved and how lipid metabolism issues trigger α-syn aggregation and neurodegeneration remain unclear. Here, we found that α-syn shows a preference for binding to lysophospholipids (LPLs), particularly targeting lysophosphatidylcholine (LPC) without relying on electrostatic interactions. LPC is capable of maintaining α-syn in a compact conformation, significantly reducing its propensity to aggregate both in vitro and within cellular environments. Conversely, a reduction in the production of cellular LPLs is associated with an increase in α-syn accumulation. Our work underscores the critical role of LPLs in preserving the natural conformation of α-syn to inhibit improper aggregation, and establishes a potential connection between lipid metabolic dysfunction and α-syn aggregation in PD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders, Ministry of Education, Shanghai Jiao Tong University, Shanghai 200030, China.
- Zhangjiang Institute for Advanced Study, Shanghai Jiao Tong University, Shanghai 200040, China.
- Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
ORCID-Profile: Chunyu Zhao
Förderung
- Major State Basic Research Development Program of China
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Chinese Academy of Sciences, Shanghai Branch
Zitieren
APA
Zhao, C., Tu, J., Wang, C., Liu, W., Gu, J., Yin, Y., Zhang, S., Li, D., Diao, J., Zhu, Z. J., & Liu, C. (2024). Lysophosphatidylcholine binds α-synuclein and prevents its pathological aggregation. National Science Review, 11(6). https://doi.org/10.1093/nsr/nwae182
Vancouver
Zhao C, Tu J, Wang C, Liu W, Gu J, Yin Y, et al. Lysophosphatidylcholine binds α-synuclein and prevents its pathological aggregation. National Science Review. 2024;11(6). doi:10.1093/nsr/nwae182
BibTeX
@article{Zhao2024,
author = {Zhao, Chunyu and Tu, Jia and Wang, Chuchu and Liu, Wenbin and Gu, Jinge and Yin, Yandong and Zhang, Shengnan and Li, Dan and Diao, Jiajie and Zhu, Zheng-Jiang and Liu, Cong},
title = {Lysophosphatidylcholine binds α-synuclein and prevents its pathological aggregation},
journal = {National Science Review},
year = {2024},
volume = {11},
number = {6},
doi = {10.1093/nsr/nwae182}
}
EUVIMED